ANVISA – Proposal for new Bioavailability/ Bioequivalence (BA/BE) Studies

On January 2, 2020 ANVISA published in the Brazil the Public Consultation Nº 760 which provides on criteria for conducting studies of Bioavailability/Bioequivalence (BA/ BE).

The proposal aims to update RE 1170/2006 about some legal requirements in regulatory convergence with the United States and European countries.

The Public Consultation is open from today 9th January 2020, and the deadline for contributions is 8th August 2020.

Count on Vita to conduct your regulatory projects in Europe and Latin America.

Contact us: info@vitaraconsulting.com